Regeneron Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Regeneron Pharmaceuticals patents 168 in total
Status | Patent |
---|---|
Application | Utility: NON-HUMAN ANIMALS CAPABLE OF DH-DH REARRANGEMENT IN THE IMMUNOGLOBULIN HEAVY CHAIN CODING SEQUENCES Filling date: 7 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: Antibodies Comprising Chimeric Constant Domains Filling date: 7 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: Inhibition Of HSD17B13 In The Treatment Of Liver Disease In Patients Expressing The PNPLA3 I148M Variation Filling date: 7 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 7 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: SUPPORT FOR TEST DEVICE Filling date: 7 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: METHODS OF INCREASING STRENGTH AND FUNCTIONALITY WITH GDF8 INHIBITORS Filling date: 7 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: ANTIBODIES, AND BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND HER2 AND/OR APLP2, CONJUGATES, AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: HUMANIZED DIPEPTIDYL-PEPTIDASE IV (DPP4) ANIMALS Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: METHODS FOR WHOLE-CELL GLYCOPROTEOMIC ANALYSIS Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: USE OF LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY TO CHARACTERIZE OLIGONUCLEOTIDES Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Platform for Native Liquid Chromatography-Mass Spectrometry Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: High Confidence Compound Identification by Liquid Chromatography-Mass Spectrometry Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: NON-HUMAN ANIMALS COMPRISING A HUMANIZED PNPLA3 LOCUS AND METHODS OF USE Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: Tandem Mass Tag Multiplexed Quantitation of Post-Translational Modifications of Proteins Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Showing 150 to 168 of 168 patents.